Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1/2 2 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Leukemia 2 Recurrence 1 Lymphoma, B-Cell 1 Hodgkin Disease 1

Interventions

Rituximab 2 loncastuximab tesirine 1 etoposide phosphate 1 blinatumomab 1 Tubercidin 1 Immunotherapy, Adoptive 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Lymphoma, B-Cell × etoposide phosphate × Clear all

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡